查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855799

2025年人工智慧临床试验方案可行性工俱全球市场报告

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧临床试验方案可行性工具的市场规模呈指数级增长，从2024年的6.5亿美元增长到2025年的8.3亿美元，复合年增长率达27.5%。预测期内的成长主要受以下因素驱动：临床试验通讯协定日益复杂、临床试验资料量不断增加、传统临床试验成本上升、数位医疗记录的普及以及对以患者为中心的临床试验的日益重视。

预计未来几年，人工智慧临床试验方案可行性工具市场将呈指数级增长，到2029年市场规模将达到21.7亿美元，复合年增长率（CAGR）为27.1%。预测期内的成长主要受以下因素驱动：对个人化医疗试验的需求不断增长、分散式临床试验的日益普及、自然语言处理技术的广泛应用、对试验中患者多样性的日益重视，以及临床实验可行性监测的重要性日益凸显。预测期内的关键趋势包括：用于优化试验中心选择的自适应演算法的开发、基因组数据的整合以实现精准的临床实验通讯协定、自动化临床实验成本和持续时间预测的创新、用于提高患者多样性的工具的开发，以及多来源真实世界证据的整合以实现准确的可行性评估。

人工智慧临床试验方案可行性工具是一种软体解决方案，它利用人工智慧演算法分析历史临床数据、患者族群和试验设计参数，以评估提案临床试验的可行性。其主要目标是透过预测患者招募的可能性、识别通讯协定风险和优化临床试验设计，来减少临床试验的延误并提高成功率。

人工智慧临床试验方案可行性工具的关键组成部分是软体和服务。软体包括利用人工智慧评估临床试验通讯协定、预测患者招募、识别风险并优化研究设计以提高试验效率的数位平台。这些解决方案可透过云端基础或本机部署系统进行部署。应用领域包括方案设计、研究中心选择、病患招募、风险评估等与临床试验相关的功能。主要最终用户包括製药和生物技术公司、委外研发机构(CRO)、学术和研究机构以及相关组织。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，该系列报告提供人工智慧临床试验方案可行性工具市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商业机会，以及在人工智慧临床试验方案工具行业取得成功所需的数据。本人工智慧临床试验方案可行性工具市场研究报告提供您所需的一切信息，并对该行业的现状和未来发展趋势进行详细分析。

精准医疗日益受到重视，预计将推动人工智慧临床试验方案可行性工具市场的成长。精准医疗是一种客製化的医疗保健方法，它利用患者的基因谱、环境暴露和生活方式来制定更有效、更具针对性的治疗策略。基因序列测定和生物标记发现技术的进步使得早期检测和高度标靶治疗成为可能，加速了这一趋势。基于人工智慧的临床试验方案可行性工具在精准医疗中发挥关键作用，它们能够实现数据驱动的试验设计，并加强试验方案与特定患者亚群的匹配。这些工具透过预测患者招募成功率、试验进度和潜在风险来提高临床试验效率，最终提高研究结果的准确性和有效性。例如，2024年3月，总部位于澳洲的生物技术公司诺沃泰克（Novotec）报告称，2023年美国食品药物管理局）核准的217种癌症药物中，43%是精准疗法。此外，其中78种治疗方法采用了基于DNA或次世代定序仪的生物标记。因此，对精准医疗的日益重视极大地促进了人工智慧临床试验方案可行性工具市场的扩张。

为了提高方案的准确性并最大限度地减少临床研究的延误，该市场的主要企业正优先开发先进的解决方案，例如基于预测分析的试验规划工具。基于预测分析的临床试验规划利用历史数据和即时数据来评估试验的可行性、预测成本和进度，并识别营运风险。这些工具透过减少对人工流程的依赖并支持试验期间的适应性反应，从而增强试验的设计和执行。例如，总部位于美国的临床智慧公司 Lokavant Incorporated 于 2024 年 6 月推出了 Spectrum，这是第一个旨在支援整个临床试验生命週期可行性规划的人工智慧平台。该平台整合了即时临床试验数据，并支援持续的预测、风险评估和入组方案评估。透过提供对预计进度、支出和招募结果的准确预测，Spectrum 支援及时、数据驱动的决策，帮助试验团队提高效率并减少代价高昂的延误。

2025年3月，总部位于美国的医疗科技公司Tempus AI Incorporated收购了Deep 6 AI，具体金额未揭露。此举旨在提高病患招募效率，扩大真实世界临床数据的取得途径，并推动人工智慧在临床试验配对和精准医疗领域的应用。 Deep 6 AI是一家总部位于美国的科技公司，专注于开髮用于评估临床试验通讯协定可行性的人工智慧工具。

人工智慧临床试验方案可行性工具市场包括营业单位透过病患招募分析、中心选择优化、方案设计可行性、风险评估与缓解以及资料整合与分析服务所产生的收入。市场价值包括服务供应商销售的或包含在其服务产品中的相关商品的价值。仅包括在营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧临床试验方案可行性工具：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球人工智慧临床试验方案可行性工具市场：成长率分析
  • 全球人工智慧临床试验方案可行性工具市场表现：规模与成长，2019-2024年
  • 全球人工智慧临床试验方案可行性工具市场预测：规模与成长，2024-2029年，2034年预测
  • 全球人工智慧临床试验方案可行性工具：潜在市场规模 (TAM)

第六章 市场细分

  • 全球人工智慧临床试验方案可行性工具市场：按组件划分，实际值和预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 软体
  • 服务
  • 全球人工智慧临床试验方案可行性工具市场：按部署模式、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 云端基础的
  • 本地部署
  • 全球人工智慧临床试验方案可行性工具市场：按应用、实际结果和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 通讯协定设计
  • 位置选择
  • 病患招募
  • 风险评估
  • 其他用途
  • 全球人工智慧临床试验方案可行性工具市场：依最终用户划分，实际值和预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 製药和生物技术公司
  • 研究合约组织
  • 学术研究机构
  • 其他最终用户
  • 全球人工智慧临床试验方案可行性工具市场：按软体、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 预测分析
  • 机器学习
  • 自然语言处理
  • 数据集成
  • 全球人工智慧临床试验方案可行性工具市场：按服务、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 咨询
  • 执行
  • 培训和支持
  • 託管服务

第七章 区域和国家分析

  • 全球人工智慧临床试验方案可行性工具市场：区域分析、预测及成长，2019-2024年、2024-2029年预测、2034年预测
  • 全球人工智慧临床试验方案可行性工具市场：按国家/地区划分，实际结果和预测，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 人工智慧临床试验方案可行性工具市场：竞争格局
  • 人工智慧临床试验方案可行性工具市场：公司简介
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • SAS Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Veeva Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Tempus AI Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cytel Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • ArisGlobal LLC.
  • Saama Technologies Inc.
  • Norstella
  • ConcertAI
  • Komodo Health Inc.
  • H1 Inc.
  • TriNetX Inc.
  • ObjectiveHealth LLC
  • Lokavant Inc.
  • Inato Inc.
  • Clinerion Ltd.
  • Faro Health Inc.
  • Lantern Pharma Inc.
  • Ryght AI
  • BEKHealth Corporation

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年人工智慧临床试验方案可行性工具市场：提供新机会的国家
  • 人工智慧临床试验方案可行性工具市场展望（2029）：新兴细分市场机会
  • 2029年人工智慧临床试验方案可行性工具市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38448

An artificial intelligence clinical trial protocol feasibility tool is a software solution that leverages AI algorithms to analyze historical clinical data, patient populations, and trial design parameters to evaluate the feasibility of a proposed clinical trial. Its main purpose is to predict patient recruitment potential, identify protocol risks, and optimize trial design, helping reduce delays and improve trial success rates.

The primary components of the artificial intelligence clinical trial protocol feasibility tool are software and services. Software includes digital platforms that use AI to assess clinical trial protocols, predict patient recruitment, identify risks, and optimize trial design for more efficient studies. These solutions are deployed through cloud-based or on-premises systems. Applications include protocol design, site selection, patient recruitment, risk assessment, and other trial-related functions. Key end-users include pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, and related organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence clinical trial protocol feasibility tool market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence clinical trial protocol feasibility tool market statistics, including artificial intelligence clinical trial protocol feasibility tool industry global market size, regional shares, competitors with a artificial intelligence clinical trial protocol feasibility tool market share, detailed artificial intelligence clinical trial protocol feasibility tool market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence clinical trial protocol feasibility tool industry. This artificial intelligence clinical trial protocol feasibility tool market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence clinical trial protocol feasibility tool market size has grown exponentially in recent years. It will grow from $0.65 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 27.5%. The growth in the historic period is attributed to the increasing complexity of clinical trial protocols, growing volume of clinical trial data, rising costs of traditional trials, increasing adoption of digital health records, and greater focus on patient-centric trials.

The artificial intelligence clinical trial protocol feasibility tool market size is expected to see exponential growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth in the forecast period is driven by rising demand for personalized medicine trials, increased adoption of decentralized clinical trials, growing use of natural language processing, emphasis on patient diversity in trials, and the growing importance of real-time feasibility monitoring. Key trends in the forecast period include the development of adaptive algorithms for site selection optimization, integration of genomic data to enable precision trial protocols, innovation in automated trial cost and timeline estimation, creation of tools to enhance patient diversity, and integration of multi-source real-world evidence for accurate feasibility assessments.

The increasing focus on precision medicine is anticipated to support the growth of the artificial intelligence clinical trial protocol feasibility tool market. Precision medicine is a customized approach to healthcare that utilizes a patient's genetic profile, environmental exposure, and lifestyle to develop more effective and tailored treatment strategies. This emphasis is accelerating due to ongoing advancements in genomic sequencing and biomarker discovery, which allow for earlier detection and highly targeted therapies. Artificial intelligence-based clinical trial protocol feasibility tools play a critical role in precision medicine by enabling data-driven trial design and enhancing the alignment of study protocols with specific patient subgroups. These tools improve clinical trial efficiency by forecasting patient recruitment success, timelines, and potential risks, ultimately increasing the accuracy and effectiveness of research outcomes. For example, in March 2024, Novotech, a biotechnology company based in Australia, reported that in 2023, forty-three percent of the two hundred seventeen oncology therapies approved by the Food and Drug Administration in the United States were precision treatments. Additionally, seventy-eight of these therapies utilized DNA-based or next-generation sequencing biomarkers. Therefore, the growing emphasis on precision medicine is contributing significantly to the expansion of the artificial intelligence clinical trial protocol feasibility tool market.

Leading companies in this market are prioritizing the development of advanced solutions, such as trial planning tools powered by predictive analytics, to improve protocol accuracy and minimize delays in clinical research. Predictive analytics-driven trial planning refers to the use of historical and real-time data to assess study feasibility, forecast costs and timelines, and identify operational risks. These tools enhance trial design and execution by reducing reliance on manual processes and enabling adaptive responses during the study. For instance, in June 2024, Lokavant Incorporated, a clinical intelligence firm based in the United States, introduced Spectrum, the first artificial intelligence platform designed to support feasibility planning throughout the full clinical trial lifecycle. This platform integrates live clinical trial data and enables continuous forecasting, risk assessment, and enrollment scenario evaluation. Spectrum supports timely, data-informed decision-making by providing accurate estimates of projected timelines, expenditures, and recruitment outcomes, helping study teams improve efficiency and reduce costly delays.

In March 2025, Tempus AI Incorporated, a health technology company based in the United States, completed the acquisition of Deep 6 AI for an undisclosed amount. This strategic move aims to improve patient recruitment efficiency, broaden access to real-world clinical data, and advance the application of artificial intelligence in clinical trial matching and precision medicine. Deep 6 AI is a United States-based technology company that specializes in artificial intelligence tools for evaluating clinical trial protocol feasibility.

Major players in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, and BEKHealth Corporation.

North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence clinical trial protocol feasibility tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence clinical trial protocol feasibility tool market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence clinical trial protocol feasibility tool market includes revenues earned by entities through patient recruitment analysis, site selection optimization, protocol design feasibility, risk assessment and mitigation, and data integration and analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence clinical trial protocol feasibility tool market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence clinical trial protocol feasibility tool ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence clinical trial protocol feasibility tool market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services
  • 2) By Deployment Mode: Cloud-Based; On-Premises
  • 3) By Application: Protocol Design; Site Selection; Patient Recruitment; Risk Assessment; Other Applications
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Software: Predictive Analytics; Machine Learning; Natural Language Processing; Data Integration
  • 2) By Services: Consulting; Implementation; Training And Support; Managed Services
  • Companies Mentioned: IQVIA Holdings Inc.; SAS Institute Inc.; Veeva Systems Inc.; Tempus AI Inc.; Cytel Inc.; ArisGlobal LLC.; Saama Technologies Inc.; Norstella; ConcertAI; Komodo Health Inc.; H1 Inc.; TriNetX Inc.; ObjectiveHealth LLC; Lokavant Inc.; Inato Inc.; Clinerion Ltd.; Faro Health Inc.; Lantern Pharma Inc.; Ryght AI; BEKHealth Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Characteristics

3. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Trends And Strategies

4. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Total Addressable Market (TAM)

6. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Segmentation

  • 6.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premises
  • 6.3. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protocol Design
  • Site Selection
  • Patient Recruitment
  • Risk Assessment
  • Other Applications
  • 6.4. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics
  • Machine Learning
  • Natural Language Processing
  • Data Integration
  • 6.6. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting
  • Implementation
  • Training And Support
  • Managed Services

7. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 8.1. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 9.1. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 9.2. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 10.1. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 11.1. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 11.2. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 12.1. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 13.1. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 14.1. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 14.2. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 15.1. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 15.2. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 16.1. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 17.1. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 18.1. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 19.1. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 20.1. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 21.1. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 21.2. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 22.1. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 23.1. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 23.2. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 24.1. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 24.2. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 25.1. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 25.2. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 26.1. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 26.2. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 27.1. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 28.1. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 28.2. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 29.1. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 29.2. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Landscape
  • 30.2. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Company Profiles
    • 30.2.1. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. SAS Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Veeva Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Tempus AI Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cytel Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Other Major And Innovative Companies

  • 31.1. ArisGlobal LLC.
  • 31.2. Saama Technologies Inc.
  • 31.3. Norstella
  • 31.4. ConcertAI
  • 31.5. Komodo Health Inc.
  • 31.6. H1 Inc.
  • 31.7. TriNetX Inc.
  • 31.8. ObjectiveHealth LLC
  • 31.9. Lokavant Inc.
  • 31.10. Inato Inc.
  • 31.11. Clinerion Ltd.
  • 31.12. Faro Health Inc.
  • 31.13. Lantern Pharma Inc.
  • 31.14. Ryght AI
  • 31.15. BEKHealth Corporation

32. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

34. Recent Developments In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

35. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer